SB Bioseutica OVOTRANSFERRIN

BIOSEUTICA BV has been created in 2008 after the merger of Neova Technologies Inc. and KD-PHARMA GmbH. In 2013 a majority stake of KD-PHARMA GmbH has been sold to a german private equity.

Bioseutica’s subsidiaries, Fordras SA, Neova Technologies Inc. and Bioseutica BV are experts in the extraction and purification of egg proteins which form the Lysozyme and Ovoproducts division.

Eggs are a rich natural source of proteins with diverse properties and functionality. Bioseutica is expert in the extraction and purification of egg proteins which form  the Egg Proteins division. Our egg proteins are extracted from from natural, renewable sources of hen egg-white suitable for human consumption and, are manufactured without the use of GMO or recombinant technologies.